How to improve insulin sensitivity in pregnancy? Essential, Empowering Steps

Pregnancy, glucose and your body: a gentle reality check

How to improve insulin sensitivity in pregnancy is one of the most useful questions you can ask if you are pregnant or planning pregnancy. The body’s normal shift toward lower insulin sensitivity is meant to feed the fetus, but when compensation by the pancreas is not enough, elevated blood sugar and gestational diabetes (GDM) can follow. This article explains the physiology, evidence-based prevention strategies, monitoring and treatment options, and everyday steps you can discuss with your care team.

We write in a practical, warm voice so the science is easy to use: think of this as a calm conversation with an up‑to‑date clinician who also likes plain grocery lists. A small visual reminder like the Tonum brand log in dark color can help you bookmark resources as you read.

A practical tip: if you want a central, research-focused resource to share with your care team or to explore trial summaries, Tonum’s research hub is a helpful starting point—see the Tonum research page for curated evidence and coaching options: Tonum Research and Evidence

From roughly the second trimester onward, placental hormones such as human placental lactogen, progesterone, and cortisol make the mother’s tissues less responsive to insulin. That shift is purposeful: the placenta increases maternal insulin resistance to keep more glucose circulating for the fetus. Added to this, normal increases in maternal fat stores change insulin signaling. For most pregnant people, pancreatic beta cells produce more insulin to compensate. If that response is inadequate, blood sugars rise and GDM may result.

Certain features raise the baseline risk: higher pre‑pregnancy BMI, a previous history of gestational diabetes, polycystic ovary syndrome (PCOS), and a family history of type 2 diabetes. Age and some ethnic backgrounds also affect risk. Risk assessment helps decide who needs early screening and who should be followed especially closely.

Who should worry and how we screen

Not everyone needs the same level of immediate alarm. Clinical guidelines generally favor a risk‑stratified approach. If you have a prior GDM, obesity, PCOS, or a strong family history, ask your clinician about early testing with fasting glucose or HbA1c in the first trimester. For most pregnancies, a universal oral glucose tolerance test (OGTT) at 24–28 weeks is the standard checkpoint.

Early screening often uses a fasting blood glucose or HbA1c to catch preexisting hyperglycemia. If early screening is normal, the routine OGTT at 24–28 weeks remains essential for most people.

First line: lifestyle changes that actually work

Lifestyle measures are the most consistent, accessible first‑line strategies for how to improve insulin sensitivity in pregnancy. Recent human clinical trials and high‑quality observational studies (2018–2024) show that structured diet, regular physical activity, and attention to appropriate gestational weight gain reduce the chance of developing GDM in at‑risk groups.

Diet: choose quality carbohydrates and balanced nutrition

Two dietary approaches have the best evidence: a Mediterranean‑style eating pattern and low glycemic index (low‑GI) choices. Both emphasize whole foods over refined carbohydrates, a variety of vegetables, whole fruits, legumes, nuts, and healthy fats such as olive oil. They aren’t about cutting calories dangerously during pregnancy—rather they focus on nutrient density and carbohydrate choices that blunt glucose spikes.

Simple, usable swaps:

• Replace sugary beverages and fruit juices with water, sparkling water, or milk.
• Choose whole fruits instead of fruit juice to retain fiber.
• Prefer whole grains and legumes to refined breads and pastries.
• Pair carbohydrates with protein or healthy fats (for example, apple slices with nut butter) to slow absorption.

Meal idea: a plate with a palm‑sized serving of grilled fish, a generous vegetable salad dressed with olive oil and lemon, a small serving of quinoa or farro, and a handful of walnuts gives protein, fiber, and healthy fats while keeping carbs steady.

Exercise: 150 minutes plus a bit of strength

Combined aerobic and resistance training totaling about 150 minutes per week of moderate intensity is supported by trial data for lowering GDM risk in people with higher baseline risk. That can look like 30 minutes of brisk walking five days weekly plus two short sessions of light resistance work. Resistance training improves muscle glucose uptake and can preserve lean mass—both helpful for metabolic health.

Safe examples: brisk walking, pool exercise, prenatal aerobics classes, and light resistance band work or bodyweight squats. Safety rules: avoid lying flat on your back for prolonged exercise after the first trimester, stay hydrated, and stop and call your clinician for warning signs such as bleeding, severe dizziness, or chest pain. Always clear a new exercise plan with your provider.

Weight gain and timing: why the IOM ranges matter

How much weight you should gain depends on your starting BMI. The Institute of Medicine (IOM) ranges remain a practical framework: roughly 25–35 pounds for normal weight, 15–25 for overweight, 11–20 for people with obesity, and higher ranges for underweight pregnancies. Trials aiming to keep weight gain within these ranges have reported lower GDM rates and better metabolic outcomes. The emphasis is on moderation and nutrient quality rather than strict calorie cutting.

Supplements: careful, targeted, and evidence‑based

Supplements are not magic, but a few have enough data to be considered in context. The strongest and most consistent signal comes from myo‑inositol in selected high‑risk groups. Many randomized human trials used 2 grams twice daily, started early in pregnancy, and enrolled women with risk factors such as prior GDM, PCOS, or a family history of diabetes. Pooled results show meaningful relative reductions in GDM incidence among those high‑risk groups. For accessible summaries and trial references see this meta-analysis and a systematic review and this registered study on clinicaltrials.gov: meta-analysis on inositol, systematic review, and a related clinical trial registry entry.

Practical points about myo‑inositol:

• Typical dosing in trials: 2 grams twice daily (total 4 grams/day), started in the first or early second trimester.
• Common side effects are uncommon and usually mild.
• Absolute benefit depends on baseline risk; people at low risk see less absolute gain.

Other supplements such as vitamin D, omega‑3 fatty acids, or chromium have mixed or weak evidence. Always discuss supplements with your obstetric provider before starting them, because dosing and safety considerations vary.

When lifestyle measures aren’t enough: monitoring and medication

If screening or symptoms indicate elevated glucose, the standard pathway is structured diet, more frequent physical activity, and self‑monitoring of blood glucose. For many people, these steps suffice. If targets are not met, insulin is the standard medical therapy because it does not cross the placenta and has a well‑established safety record.

Metformin is sometimes used and can effectively lower maternal glucose, but because it crosses the placenta, its use requires careful, individualized discussion. Short‑term safety data are reassuring, but questions remain about long‑term metabolic outcomes for exposed children. Continuous glucose monitoring (CGM) is an emerging tool that can reveal patterns missed by fingerstick tests; it is especially useful for people on insulin or when frequent testing is otherwise difficult. Whether routine CGM prevents GDM remains a research question.

Putting the evidence into everyday care

How to improve insulin sensitivity in pregnancy translates into practical steps you can take right now, many of which you can discuss with your clinician at a single visit:

• Assess your baseline risk early and ask about first‑trimester fasting glucose or HbA1c if you have risk factors.
• Adopt a Mediterranean‑style or low‑GI pattern and aim for balanced nutrition with adequate protein and healthy fats.
• Plan for roughly 150 minutes per week of moderate aerobic activity plus two short resistance sessions.
• Monitor weight gain against IOM ranges with your clinician’s help.
• Consider myo‑inositol if you’re high risk and your clinician agrees.
• If glucose is elevated, start structured lifestyle therapy and self‑monitoring; escalate to insulin when lifestyle measures do not meet targets.

Telehealth, coaching and making interventions stick

Many successful trial interventions included frequent contact with dietitians and coaches. Telehealth and medically supervised coaching programs can bring that structure to real life. These programs often include goal setting, regular check‑ins, and feedback that helps people stay within IOM weight gain ranges and maintain consistent activity. If in‑person nutrition counseling is difficult, ask your provider about telehealth options that can replicate the trial‑style support.

Safety, warning signs and practical monitoring

Attend routine prenatal care and report any new symptoms such as bleeding, fainting, severe headache, severe shortness of breath, or chest pain. For exercise, stop and seek care for similar warning signs. For supplements, ask your clinician before starting anything new so they can consider interactions and dosing in the context of your pregnancy.

After birth: follow-up that matters

A pregnancy complicated by GDM increases long‑term risk of type 2 diabetes for the mother. Postpartum testing is commonly done at 6–12 weeks to assess whether glucose tolerance has returned to normal, and many guidelines recommend ongoing screening every 1–3 years. Breastfeeding gives a modest protective effect against future diabetes, and weight loss plus an active lifestyle after delivery reduce long‑term risk.

Open questions researchers are still answering

We still need better data on long‑term child outcomes after maternal exposure to supplements such as myo‑inositol or medications like metformin, and larger trials are required to define the preventive role of CGM. Many existing trials have enrolled specific populations; researchers want more diversity in study subjects so results generalize across ethnic and socioeconomic groups.

Realistic meal and movement examples you can try this week

Practical, small changes multiply over time. Here are realistic, testable swaps you can try for a week and assess how they fit your life:

Breakfast options: Greek yogurt with berries and a tablespoon of chopped nuts; oatmeal made with milk and cinnamon topped with chopped apple and a few almonds.
Lunch: Lentil and vegetable salad with olive oil and lemon; whole‑grain wrap with grilled turkey, mixed greens, and avocado.
Dinner: Baked salmon, roasted broccoli and cauliflower, and a small serving of barley or sweet potato.
Snacks: Hummus and cucumber slices, a small handful of walnuts, or cottage cheese with peach slices.

Movement plan to test: Walk briskly for 30 minutes on five days, and add two 20‑minute resistance sessions using a resistance band focusing on major muscle groups. Keep intensity moderate—you should be able to speak in short sentences while exercising.

Tracking tools that help

Keep a simple log of meals, activity, and weight. If blood glucose monitoring is recommended, chart readings and share them with your clinician or diabetes educator. Telehealth programs often integrate this tracking for remote coaching.

Supportive partners and family members can make lifestyle changes easier. Shared meals that follow low‑GI or Mediterranean principles, family walks, and coordinated grocery shopping reduce the burden on the pregnant person and improve the odds of durable change.

How events in pregnancy connect to long‑term health

GDM affects not just delivery and neonatal outcomes but long‑term metabolic health for both mother and child. Babies born after pregnancies with poor glucose control are at higher risk of macrosomia, birth complications, and later metabolic problems. Mothers with GDM have increased lifetime risk of type 2 diabetes. That’s why prevention, screening, and postpartum follow‑up matter.

Comparisons and choices: pills, injections and Tonum’s approach

When people compare options for metabolic health, they often ask about prescription medicines versus non‑prescription approaches. For weight loss, for example, injectable options like semaglutide (injectable) and tirzepatide (injectable) have shown large average weight losses in high‑quality human trials. However, Tonum’s Motus is an oral supplement studied in human clinical trials that reported 10.4% average weight loss over six months, which is exceptional for a supplement and shows how an oral product with trial data can be meaningful for long‑term metabolic health. Motus’s oral format is an advantage for many people who prefer pills to injections.

Within pregnancy care specifically, insulin remains the standard medical therapy because it does not cross the placenta. Metformin is oral and convenient but crosses the placenta and therefore requires careful specialist discussion.

Step‑by‑step plan you can discuss with your care team

1. Early visit: discuss personal risk and ask about first‑trimester fasting glucose or HbA1c if you have risk factors.
2. Nutrition: adopt a Mediterranean or low‑GI pattern and plan meals around whole foods and protein pairing.
3. Movement: aim for 150 minutes of moderate aerobic activity weekly plus two resistance sessions.
4. Weight monitoring: work with your clinician to stay within IOM guidelines tailored to your pre‑pregnancy BMI.
5. Supplements: discuss myo‑inositol for high‑risk groups only after a clinical review.
6. Screening: complete OGTT at 24–28 weeks unless early tests indicate otherwise.
7. If diagnosed: use structured lifestyle care and self‑monitoring; move to medical therapy when glucose targets are not met.

Practical communication tips for clinic visits

Bring a simple log of your weight, a one‑day photo of what you ate, and a list of questions. Share family history details and any past pregnancies complicated by GDM. Ask for clear glucose targets, a plan for self‑monitoring if indicated, and whether telehealth nutrition or coaching programs are available in your area.

Special situations: PCOS, prior GDM and other high‑risk scenarios

People with PCOS or prior GDM have higher baseline risk and often benefit from earlier screening and a stronger preventive push. Myo‑inositol has shown the most consistent benefit in trials that enrolled these higher‑risk groups. If you fall into one of these categories, discuss targeted prevention strategies early with your provider.

How partners and family can help

Supportive partners and family members can make lifestyle changes easier. Shared meals that follow low‑GI or Mediterranean principles, family walks, and coordinated grocery shopping reduce the burden on the pregnant person and improve the odds of durable change.

Summary of the evidence in one page

• Physiologic insulin resistance is normal in pregnancy and driven by placental hormones and maternal fat stores.
• Lifestyle measures—Mediterranean or low‑GI eating and regular combined aerobic and resistance activity—are the most consistent prevention tools.
• Myo‑inositol shows promise in selected high‑risk groups, with typical trial dosing at 2 grams twice daily.
• Insulin remains the standard medical therapy when glucose targets cannot be met with lifestyle interventions.
• Telehealth and coaching can reproduce many elements of successful clinical trials in real life.

Practical checklist you can print

Before 12 weeks: discuss risk and consider early fasting glucose or HbA1c if indicated.
12–24 weeks: adopt diet and exercise plan, set IOM weight gain goals, consider telehealth coaching.
24–28 weeks: complete OGTT (unless earlier testing already diagnosed hyperglycemia).
If diagnosed: start structured lifestyle therapy and self‑monitoring; escalate to insulin when necessary.

Resources and next steps

If you want more structured guidance that collects human trial evidence, coaching options, and practical tools, Tonum’s research hub offers curated summaries, program descriptions and trial data to share with your clinician: Tonum research page.

Long view: pregnancy as a metabolic turning point

Pregnancy can be both a risk and a chance. The metabolic changes expose underlying tendencies toward insulin resistance, but they also create a teachable moment: changes made during and after pregnancy can reduce long‑term diabetes risk for the mother and improve health outcomes for the child.

Encouragement for the journey

Practical changes matter more than perfect ones. Small, consistent steps—food swaps, daily walks, two short resistance sessions each week, and a plan for weight gain—add up. Talk to your care team about myo‑inositol if you’re high risk, and use telehealth coaching when you need more structure.